Recent Updates
Recently added Catalysts
LMAT Positive Sentiment

LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference

Key Takeaway: LeMaitre Vascular, Inc. will present at the Bank of America Securities 2025 Healthcare Conference on May 13, 2024. David Roberts, the President of LeMaitre, will lead the presentation at the Encore at the Wynn Hotel in Las Vegas, NV. The company specializes in devices for treating peripheral vascular disease.
Price reaction · baseline $80.44 (2025-05-05 close) · hit after-hours · clean, no other LMAT news in the window
day 0 close · peak
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • LeMaitre is actively participating in a significant healthcare conference.
  • The presentation may enhance visibility and networking opportunities.
  • The company is focused on addressing a major health issue affecting millions.

Full Press Release Details

BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024, at 5:00 PM PDT at the Encore at the Wynn Hotel in Las Vegas, NV.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Frequently Asked Questions

When will LeMaitre present at the conference?

LeMaitre will present on May 13, 2024, at 5:00 PM PDT.

Who will represent LeMaitre at the conference?

David Roberts, the President of LeMaitre, will represent the company.

Where is the conference taking place?

The conference will be held at the Encore at the Wynn Hotel in Las Vegas, NV.

What does LeMaitre specialize in?

LeMaitre specializes in devices for the treatment of peripheral vascular disease.

Last updated: May 5, 2025